⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KROS News
Keros Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
KROS
Form 8-K
sec.gov
KROS
Keros Therapeutics Reports Second Quarter 2026 Financial Results
globenewswire.com
KROS
Form 8-K
sec.gov
KROS
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
globenewswire.com
KROS
Form 8-K
sec.gov
KROS
Form 8-K
sec.gov
KROS
Keros Therapeutics Appoints Anne Prener to its Board of Directors
globenewswire.com
KROS
Form 8-K
sec.gov
KROS
Form 8-K
sec.gov
KROS